Reduction observed in RSV-related hospitalizations in adults aged ≥60 years 1 An observed reduction in major adverse ...

Respiratory syncytial virus (RSV) vaccines were an estimated 79% effective against dangerous virus-related blood clots among ...

Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory ...

Beyfortus is not a vaccine. It’s a monoclonal antibody designed to help protect babies from serious RSV lung infection during ...

Clinicians underutilize RSV testing in adults with respiratory or cardiac exacerbations, potentially obscuring the true burden of disease.

Adults hospitalized with a respiratory syncytial virus infection have an increased risk for cardiorespiratory events in the weeks afterward, according to a retrospective analysis.

From early failures to prefusion F protein breakthroughs, RSV vaccine development has accelerated, reshaping prevention strategies for infants and older adults.

Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

Constant exposure to diverse diseases is an occupational hazard for all healthcare workers, especially those who work with children. | Constant exposure to diverse diseases is an occupational hazard ...

Adults should also stay up-to-date with vaccines. Here’s where to go for trusted guidance. You’re reading The Checkup With Dr ...

The vaccine became available in 2023 and has quickly gained usage in the Mountain West.